Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (63 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

Bullboard (TSXV:TLT)

View:
Comment by DeathXray33on May 06, 2024 4:39pm

RE:Chemotherapy drugs in short supply, needing new solutions

So easy; TLD-1466. Cancer gone; no harm to patient. Doctor office visit. Alamir4's correct; 10 billion start. @ 1.37 mil now.
Post by O12009on May 06, 2024 4:05pm

Chemotherapy drugs in short supply, needing new solutions

https://link.biopharmadive.com/click/35281528.98004/aHR0cHM6Ly93d3cuYmlvcGhhcm1hZGl2ZS5jb20vbmV3cy9kcnVnLXNob3J0YWdlcy1waGFybWEtcmVndWxhdGlvbnMtaGhzLWZkYS83MTUyMjgv/6623bec14feb454741087024B9bf2eeb6
Comment by Legit62on May 06, 2024 4:05pm

RE:RE:Adstiladrin Five Year Data Is Out

My same thought BlueFrankey, no insider buys this last PP, something cooking, possible insider info prevented buys??? we should hear something hopefully in June
Comment by BlueFrankyon May 06, 2024 2:34pm

RE:Adstiladrin Five Year Data Is Out

Thanks Eog.. great post! You just got to believe that the recent hires are  all hands on deck/nose to the grindstone, helping to smash us through the goal posts. GLTA!!
Comment by DJDawgon May 06, 2024 2:11pm

RE:Adstiladrin Five Year Data Is Out

Great share Eog. That boggles the mind. That many instillations to 107 patients and only 6 get to be considered home free of the cancer. Reading in more detail (although I find it confusing since ...more  
Comment by gebremeskelon May 06, 2024 1:43pm

RE:RE:RE:latest news release

You could always ask her - kaouthar.lbiati@gmail.com She may not be at liberty to share much information. I would guess she is quietly working behind the scenes. Theralase was happy enough with ...more  
Post by Eoganachton May 06, 2024 12:12pm

Adstiladrin Five Year Data Is Out

The 5 year Adstiladrin results are out. There are positive aspects to the treatment, but the 5 year complete response rate is not high. I take it that "high-grade recurrence-free" is the ...more  
Comment by Infinityon May 06, 2024 11:29am

RE:RE:latest news release

I  was just wondering what the newest Director on the TLT Borad is  doing in terms of creating awareness for this Novel treatment using the PDT.  Have not heard anything from DR ...more  
Comment by stocksnbonds458on May 06, 2024 8:48am

RE:RE:RE:RE:RE:CGON 35% 12 months CR?

Very true Toade, it's very close to 1 year now since the FDA asked for some clarification on TLT data submitted as part of the Pre-BTD application. In fact, it was last June, so next month is 1 ...more  
Post by Legit62on May 06, 2024 8:18am

BTD value

https://seekingalpha.com/article/4314267-real-value-of-breakthrough-therapy-designation
Post by 2b7f6fabon May 06, 2024 4:38am

Cancer ‘is our new Covid’ – Pfizer CEO

Another drug in the company’s portfolio that has demonstrated “phenomenal performance” is Padcev, according to Bourla. Padcev is used to treat bladder cancer, and its sales have “had a growth of ...more  
Post by Tcwtaeugene2on May 05, 2024 6:39pm

Maybe

This was post before E Study Details | Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients ...more  
Comment by Alamir1111on May 04, 2024 2:15pm

RE:RE:Tltff

https://www.otcshortreport.com/company/TLTFF
Comment by DeathXray33on May 04, 2024 1:10pm

RE:Tltff

Alamir4, What is that Short info site link? Thanks. --------------------------- Genius Group stock rallies more than 200% after it appoints former F.B.I. director to investigate alleged naked short ...more  
Post by Alamir1111on May 03, 2024 8:01pm

Tltff

Historical Short Volume Data for TLTFF Date Close High Low Volume Short Volume % of Vol Shorted May 01 NA  ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

Connect with V.TLT


Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 63 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250